Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

TCS Named a Leader and Star Performer in Life Sciences Operations by Everest Group

Posted On: 2020-02-14 16:53:30

Tata Consultancy Services (TCS) (BSE: 532540, NSE: TCS), a leading global IT services, consulting and business solutions organization, has been named a Leader and Star Performer in the Everest Group PEAK Matrix® for Life Sciences (LS) Operations.

In an assessment of 24 global life sciences service providers, TCS was positioned highest for Vision and Capability. Cited as a strength is TCS' significant scale in the LS operations services market, with solutions like its cloud-based TCS ADD platforms witnessing increased traction in the market, particularly the TCS Connected Clinical Trials™ platform, which enables patient engagement and clinical supply process visibility. The report highlights that TCS is deploying automation for multiple customers in pharmacovigilance, data management, and the medical affairs segments, which is augmented by its in-house technology engine - the TCS Decision Fabric.

TCS was positioned as a Star Performer for its addition of new customers in the clinical trials and regulatory affairs value chain segments, and investments in building solutions and its talent pool to expand into newer processes such as commercial operations and supply chain.

"Life sciences enterprises are leveraging emerging technologies and next-gen platforms to overcome the challenges that come with rising costs, declining revenues, data explosion, continued M&A pursuits, and increasingly complex regulations, as well as to drive digitization in R&D and focus on specialty drugs," said Debashis Ghosh, Business Group Head, Life Sciences and Healthcare, TCS. "This leadership position is a validation of our vision and strategy, global scale, portfolio of domain-focused platform solutions, and the resultant market impact."

TCS collaborates with leading life sciences companies to enable their digital transformation journey by leveraging its Business 4.0™ framework and Machine First™ Delivery Model (MFDM™). TCS offers a full set of business operations and transformation services and solutions including advisory services, predictive and prescriptive analytics, clinical operations, regulatory services, laboratory platforms, AI / ML solutions, pharmacovigilance, genomics research, blockchain, and medical articles and medico marketing. Early investments in re-skilling the workforce, building agile workplaces, and developing intellectual property have helped TCS gain significant scale and depth in digital technologies.

The company's extensive portfolio of intellectual property - including the award winning TCS ADD platform suite, Real World Evidence platform, Decision Fabric™ engine, TCS Connected Clinical Trials™ platform and Translational Research Platform - help customers achieve better speed to market and superior business outcomes.

"The life sciences industry is under tremendous pressure to streamline processes, comply with regulatory norms, launch newer drugs at a faster pace, and deliver real value for patients. Under the weight of such issues, the core capability of a pharma company - innovation - can often take a back seat," says Manu Aggarwal, Vice President, Everest Group. "TCS' investments in creating an integrated platform - the Advanced Drug Development (TCS ADD) platform - along with focus on building deep domain expertise and expansion into newer services such as commercialization is bringing the focus back on drug innovation."

"Our focus on innovation, technology-driven solutions and platforms that digitize the life sciences value chain, contextual knowledge, as well as significant investments in innovation labs and upskilling of digital talent, position us as a preferred partner to drive our customers' growth and transformation agendas," added Debashis Ghosh.

Shares of TATA CONSULTANCY SERVICES LTD. was last trading in BSE at Rs.2183.8 as compared to the previous close of Rs. 2191.6. The total number of shares traded during the day was 58034 in over 4579 trades.

The stock hit an intraday high of Rs. 2211.55 and intraday low of 2170.95. The net turnover during the day was Rs. 127121733.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Ambuja Cements Ltd Q4 CY2019 consolidated PAT lower at Rs. 591.54 crore

ICRA revises long term rating of Indiabulls Housing Finance Limited

GMR Infrastructure Limited announces Strategic Partnership with Groupe ADP for Airports Business

Muthoot Finance Ltd announces pricing of USD 550 million 4.40% notes

UFO Moviez India Ltd board to consider interim dividend on Feb 27, 2020

Dr. Reddy's Laboratories Ltd receives EIR for Duvvada Formulations Plant

Dhanlaxmi Bank Ltd receives RBI nod for appointment of MD & CEO

Sharda Cropchem Ltd Board to consider Second Interim Dividend for FY20

Ambuja Cements Ltd Board recommends Dividend of Rs. 1.50 for CY2019

Plastiblends India Ltd board to consider interim dividend on Feb 25, 2020

Cyient Organizes Blood Donation Drive at its Hyderabad Campus

TCS Named as One of the Fortune Best Big Companies to Work For™ in 2020

India Infoline Finance Ltd raises $400 million

Ambuja Cements Limited appoints Mr. Neeraj Akhoury as new MD and CEO

Garware Technical Fibres Ltd to dispose business undertaking in USA

AstraZeneca Pharma India Ltd launches FDC of Dapagliflozin 10mg + Saxagliptin 5mg film coated tablets (QTERN®)

DCW Limited is the biggest beneficiary of the recently announced anti-dumping duty on imported C-PVC

Jubilant FoodWorks Ltd Board to consider interim dividend on Feb 27, 2020

Jubilant Life Sciences Ltd board to consider interim dividend for FY2020

JK Paper Ltd board to consider interim dividend on Feb 27, 2020

Shri N Baijendra Kumar, CMD, NMDC wins Business Leadership Award

Cyril Amarchand Mangaldas Advises Avenue Supermarts Limited on its INR 4098 Cr. QIP

PVR Ltd board to declare interim dividend on Feb 28, 2020

ICRA assigns ratings to KPIT Technologies Ltd

A.M. Best Affirms A-(Excellent) Rating of The New India Assurance Company Limited

Cipla Ltd board to consider interim dividend for FY2020

SBI Cards IPO to open for subscription on March 2, 2020

Axis Bank to explore long-term strategic partnership with Max Life

Genus Power wins 'Innovative Initiative in the Power Sector', 2020 award for its Smart Metering Pilot project in UAE

JK Cement Ltd board to consider interim dividend on Feb 28, 2020

Shoppers Stop Ltd closes stores at Orion East Mall, Bengaluru and Grant Mall, Chennai

KRBL Ltd board to consider interim dividend for FY2020

Future Lifestyle Fashions Ltd board approves issue of securities to IFC

Trident Ltd board declares interim dividend of Rs. 0.18

Century Plyboards India Ltd forms new subsidiary company

Valiant Organics Ltd board to consider 2nd interim dividend on Feb 28, 2020

Sonata Software Ltd board to consider interim dividend on Feb 26, 2020

JB Chemicals & Pharmaceuticals Ltd board declares interim dividend of Rs. 10

Anuh Pharma Ltd receives CEP for Ambroxol Hydrochloride for EU market

TCS Positioned as a Leader in Application Transformation Services by Everest Group

CARE Ratings Limited updates on ratings of Pitti Engineering Ltd

HGS Recognized on IAOP's 'The 2020 Global Outsourcing 100®' List

Shreyas Shipping & Logistics Ltd announces sale of Vessel 'SSL Kutch'

Redington India Ltd board approves 2nd interim dividend of Rs. 2.80

Cholamandalam Investment and Finance Company Ltd board to consider interim dividend for FY20

Tarini International Ltd updates on SEBI AO Order

Sunteck Realty Ltd has sold 1800 apartments at Sunteck MaxXWorld

Thomas Cook India Ltd board to consider buy back on Feb 26, 2020

Delhi International Airport Ltd offers $150 mn senior secured notes

IndiGo to enable faster ground operations and reduce aircraft turn-around time with WheelTug Systems







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019